Recent reports on NASH

Investigators have recently published ample data from several nonalcoholic steatohepatitis studies.Here, Healio presents some of our current reports on those data and other new developments in the treatment of NASH and other liver diseases.Q&A: Perspectum to evaluate imaging device as tool to identify NASH patientsPerspectum announced it will evaluate the use of LiverMultiScan as a diagnostic tool to identify eligible patients for enrollment into nonalcoholic steatohepatitis clinical trials. READ MOREFDA issues complete response letter for obeticholic acid for fibrosis due to NASHThe FDARead More

Share on facebook
Share on twitter
Share on linkedin